There were 1,122 press releases posted in the last 24 hours and 400,920 in the last 365 days.

Green Cures & Botanical Distribution, Inc. Increases Product Placement with the Addition of Blue Plant Farms’ CBD Products on Green Cures Platform

LOS ANGELES, March 14, 2019 (GLOBE NEWSWIRE) -- Green Cures & Botanical Distribution, Inc. (OTC: GRCU) a Colorado corporation (“Green Cures”) is pleased to announce the addition of Blue Plant Farms’ CBD products to the Company’s CBD Platform at www.grcustock.com. Blue Plant Farms has developed proprietary innovative Full Spectrum Hemp Oil products to fulfill the demand in the burgeoning pain relief market. Green Cures is strategically positioning with CBD companies that develop their products with bioavailability of CBDs as their driving force. Blue Plant Farms’ water soluble CBD compound is 90% bioavailable, making their products highly effective and in demand.

With the addition of Blue Plant Farms’ 10 CBD products, which include 20 mg CBD Blueberry Hemp-Shroom Nootropic Shot, EEZ-Away Blue extra strength w/emu, EEZ-Away Green extra strength w/emu + 300 mg CBD, 25mg CBD K Cup Millennial blend coffee, 25mg CBD K Cup Millennial blend decaf coffee, Sleepy Time Chamomile Hemp Tea K Cup, BluDog 250mg and 500mg naturally duck flavored water soluble hemp oil with c60 topical salve and BluDog 400mg naturally peanut butter/bacon flavored water soluble hemp oil with c60 topical salve Green Cures is further positioning itself for dramatic growth in 2019. In addition to Blue Plant Farms’ products being added to the platform Green Cures also is introducing 1gm CBD Distillate, 1gm CBD Isolate, CBD infused organic dried fruit and a CBD Vegan protein powder, the Blue Plant Farms products with be available on the platform within the next 10 days.

Green Cures continues to build out its platform and consolidate Hemp and Cannabis companies to provide an ecosystem of synergistic growth focusing on revenue and EBITDA, with the goal of consolidating and scaling to $15 Million in revenue for FY 2019. With the closing of Green Cures previously announced LOI quickly approaching Green Cures’ management is very confident in meeting and exceeding their FY 2019 goals.

In addition to their acquisition model Green Cures will be rolling out a comprehensive marketing campaign with a blended mix of targeted social media, celebrity product endorsements and traditional media outlets to drive revenue growth and brand awareness.

About Green Cures & Botanical Distribution, Inc. (OTC PINK: GRCU)

Green Cures & Botanical Distribution Inc., is revenue-generating company that wholesales and retails hemp-infused nutritional, botanical, sports, and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc., operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production and distribution, Green Cures & Botanical Distribution Inc., is continuously creating and introducing products that promote a healthy life style. For more information visit:  http://www.grcustock.com/.

About Blue Plant Farms, LLC.

Blue Plant Farms focuses on Hemp oil products with improved bioavailability, including water-soluble Full Spectrum Hemp Oil. Blue Plant Farms is in the business of providing wellness and optimal wellbeing. The Company consistently deliver great value and exceptional products to our customers. Blue Plant Farms is strategically introducing Full Spectrum Hemp Oil Products, some of which are water soluble and easily absorbed. Patented BPFP Full Spectrum Hemp Oil is an alternative over-the- counter therapeutic option to help relieve post-sports inflammation as well as promote relaxation and wellbeing. The Company’s  interact naturally with our bodies body’s anti-inflammatory (endocannabinoid) system. Blue Plant Farms products are formulated with Proprietary Hemp Oil extracts which deliver a full spectrum of cannabinoids and terpenes. Blue Plant Farms’ delivery system improves absorption bioavailability while maximizing benefits.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov

Contact:                                                                                                                
info@grcustock.com 

Screen Shot 2018-10-29 at 11.05.45 PM.png